ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma.

Shari Pilon-Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.